Le Lézard
Classified in: Health, Science and technology
Subject: PER

Astellas Appoints Anthony Fiordaliso to Vice President, Americas Finance


NORTHBROOK, Ill., Dec. 13, 2017 /PRNewswire/ -- Astellas today announced Anthony Fiordaliso, M.B.A., C.P.A., has been promoted to vice president, Americas Finance, reporting to Stephen Knowles, senior vice president, Finance and Information Technology. 

Anthony Fiordaliso has been promoted to vice president, Americas Finance at Astellas.

"Since joining Astellas in March 2010, Tony has held positions of increasing responsibility and has made significant contributions to our Finance organization in the Americas," said Knowles. "Tony's depth and breadth of knowledge and experience in finance related to the pharmaceutical industry position him well for his new role."

In his new position, Fiordaliso will oversee managerial reporting and budgeting, financial planning and analysis, revenue forecasting and recognition, collaboration finance and expense management for Astellas Americas, which includes United States, Canada, Brazil, Colombia and the rest of Latin America.

Previously, Fiordaliso served as executive director, Commercial Finance. Prior to joining Astellas, Fiordaliso held operations and finance positions of increasing responsibility culminating in the role of director, U.S. Financial Operations, at Schering-Plough, now Merck.  Before Schering-Plough, he served as senior internal auditor at Warner-Lambert, now Pfizer. Fiordaliso began his career at Ernst & Young, now EY, as staff auditor performing financial audits of hospitals and healthcare related entities.

Fiordaliso holds a Master of Business Administration from New York University Stern School of Business, as well as a Bachelor of Science degree in accounting from Rutgers University. He achieved licensure as a certified public accountant in the State of New Jersey in 1998.

About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at http://www.astellas.us/. You can also follow us on Twitter at @AstellasUS, Facebook at http://www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.

 

Astellas is a pharmaceutical company dedicated to improving the health of people around the world. (PRNewsFoto/Astellas Pharma Inc.)

SOURCE Astellas


These press releases may also interest you

at 12:14
Anodot publishes its annual Cloud Cost Optimization Report, delivering insights from customer data and analysis of news and trends within the FinOps sector to prepare cloud users for 2024....

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...

at 12:05
Phenom today announced IAMPHENOM ? the human resources event for talent acquisition, talent management, CHROs, HRIS and executives ? has sold out with record-breaking registrations and is reaching maximum capacity. Waitlisting is now available. The...

at 12:00
Sony Electronics Inc. today announced a new addition to its line of car AV receivers, the XAV-AX3700. The XAV-AX3700 includes a customizable experience to fit user's personal viewing preference, while providing optimal sound. This new model includes...

at 11:40
TransAlta Corporation ("TransAlta" or the "Company") announced today that it has signed onto a voluntary water-sharing memorandum of understanding ("MOU") with over thirty other water licence holders in the Bow River Basin. Water-sharing MOUs have...

at 11:40
Wipro Limited , a leading technology services and consulting company, announced financial results under International Financial Reporting Standards (IFRS) for the quarter and year ended March 31, 2024. Highlights of the Results Results for the...



News published on and distributed by: